The gut is an important reservoir for drug-resistant bacteria responsible for life-threatening hospital-acquired infections, such as Clostridium difficile (C. diff). C. diff causes inflammation of the large intestine, with an estimated half million infections in 2011, resulting in 29,000 deaths, according to the U.S. Centers for Disease Control and Prevention.
Fecal microbiota transplantation (FMT), an innovative treatment regimen, has been demonstrated to cure C. diff at a rate of over 90 percent, vastly superior to antibiotic treatment. Investigators are also testing FMT as a treatment for other conditions, such as inflammatory bowel disease and obesity. FMT replenishes the gut with "good bacteria," which can result in the disappearance of multi-drug resistant organisms from the patients' bodies and potentially save their lives.
This briefing, hosted by the American Gastroenterological Association, will provide you the opportunity to hear from and participate in a dialogue with a panel of experts from the scientific and patient care community on this exciting field of research and treatment.
Monday, Feb. 29, 2016, at Noon
Cannon House Office Building 121
Introduction and The Gut Microbiome: The "Good Bug, Bad Bug" Story
Gary D. Wu, MD
Chair, scientific advisory board, AGA Center for Gut Microbiome Research and Education
Professor of medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia
Antibiotics and the Development of Drug-Resistant Organisms?
Ebbing Lautenbach, MD, MPH, MSCE
Robert Austrian Professor of Medicine; professor of epidemiology, Perelman School of Medicine
University of Pennsylvania, Philadelphia
Current and Future Fecal Microbiota Transplantation Therapies
Colleen R. Kelly, MD
Scientific advisory board member, AGA Center for Gut Microbiome Research and Education
Center for Women's Gastrointestinal Medicine, Women's Medicine Collaborative, assistant professor of medicine, Warren Alpert Medical School, Brown University, Providence, RI
Rachel Shubert, [email protected], 301-272-1603
About the American Gastroenterological Association
The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, the AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. http://www.gastro.org.
Like AGA on Facebook.
Join AGA on LinkedIn.
Follow us on Twitter @AmerGastroAssn.
Check out our videos on YouTube.